AntibodySystem是隸屬于Reliable Bioreagents集團(tuán)的創(chuàng)新型生物科技企業(yè)，專注于為全球科研、醫(yī)療及工業(yè)領(lǐng)域提供高品質(zhì)抗體與重組蛋白解決方案。作為生物試劑供應(yīng)商，其核心業(yè)務(wù)涵蓋單克隆抗體、多克隆抗體定制服務(wù)以及功能性重組蛋白的研發(fā)生產(chǎn)，產(chǎn)品廣泛應(yīng)用于疾病機(jī)制研究、藥物靶點(diǎn)篩選、體外診斷試劑開發(fā)及生物治療等領(lǐng)域。公司依托前沿的分子生物學(xué)技術(shù)與嚴(yán)格的質(zhì)量管理體系，確保產(chǎn)品的高特異性與批間穩(wěn)定性，并通過ISO認(rèn)證體系規(guī)范生產(chǎn)流程。AntibodySystem注重產(chǎn)學(xué)研合作，定期更新抗體質(zhì)控?cái)?shù)據(jù)庫，并配備專業(yè)技術(shù)團(tuán)隊(duì)提供實(shí)驗(yàn)設(shè)計(jì)支持與售后服務(wù)，致力于加速科研轉(zhuǎn)化與產(chǎn)業(yè)創(chuàng)新。
核心優(yōu)勢(shì)
1.技術(shù)創(chuàng)新與高質(zhì)量產(chǎn)品
自主開發(fā)高效真核重組表達(dá)系統(tǒng)，確保抗體與蛋白的高特異性、低背景信號(hào)及穩(wěn)定性。
流式抗體覆蓋5000余種熱門靶點(diǎn)，支持腫瘤、免疫、病毒等領(lǐng)域研究，如SAA系列流式抗體以低內(nèi)毒素、高安全性著稱。
2.廣泛的應(yīng)用場(chǎng)景
產(chǎn)品涵蓋流式細(xì)胞術(shù)、Western Blot、免疫熒光（IF）、免疫組化（IHC）等多種實(shí)驗(yàn)技術(shù)，并適配體內(nèi)功能驗(yàn)證及藥物開發(fā)需求。
3.嚴(yán)格的質(zhì)控體系
每一批次產(chǎn)品均經(jīng)過嚴(yán)格質(zhì)檢，確保數(shù)據(jù)準(zhǔn)確性與批次一致性，支持長期科研項(xiàng)目。
4.全球化合作網(wǎng)絡(luò)
與頂尖科研機(jī)構(gòu)及藥企合作，推動(dòng)抗體藥物靶點(diǎn)發(fā)現(xiàn)與臨床轉(zhuǎn)化，如猴痘病毒抗體、CAR-T治療相關(guān)抗體等。
主要產(chǎn)品介紹：
1.Recombinant Human IL36RN Protein, N-His
IL36RN（白細(xì)胞介素36受體拮抗劑）是一個(gè)編碼蛋白質(zhì)的基因。與IL36RN相關(guān)的疾病包括14號(hào)銀屑病、掌跖膿皰病和掌跖膿皰病。其相關(guān)的通路包括IL-1家族信號(hào)通路和PEDF誘導(dǎo)信號(hào)通路。與該基因相關(guān)的基因本體（GO）注釋包括細(xì)胞因子活性和白細(xì)胞介素-1受體拮抗劑活性。IL36RN可能是中國四川地區(qū)漢族泛發(fā)性膿皰型銀屑病患者的主要致病基因。IL36RN突變與早期發(fā)病和指甲下膿皰有關(guān)，但與阿維A的治療效果或復(fù)發(fā)頻率無關(guān)。
2.Anti-Adiponectin/ACRP30/ADIPOQ Polyclonal Antibody
物種反應(yīng)性：人類, 鼠, 大鼠
宿主物種：兔子
同型：免疫球蛋白G
克隆性：多克隆
免疫原：大腸桿菌來源的重組人脂肪因子/ACRP30/ADIPOQ (Glu19-Asn244)。
已測(cè)試的應(yīng)用程序：ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
目標(biāo)：胰島素樣生長因子結(jié)合蛋白30,脂肪的基因轉(zhuǎn)錄1蛋白,腺苷酸活化蛋白,脂肪細(xì)胞基因轉(zhuǎn)錄1蛋白,APM1,ADIPOQ,apM-1,30 kDa脂肪細(xì)胞補(bǔ)體相關(guān)蛋白,脂肪細(xì)胞補(bǔ)體相關(guān)30 kDa蛋白,脂肪細(xì)胞,含C1q和膠原結(jié)構(gòu)域蛋白,膠原結(jié)合蛋白
凈化：通過抗原親和柱純化。
應(yīng)用程序：酶聯(lián)免疫吸附測(cè)定，免疫組化，蛋白質(zhì)印跡法
穩(wěn)定性和儲(chǔ)存：使用手動(dòng)除霜冷凍庫，并避免反復(fù)冷凍解凍循環(huán)。頻繁使用時(shí)存放在2至8°C。自收到之日起存放在-20至-80°C，為期十二個(gè)月。
3.Enterokinase
描述：腸激酶是一種特異性蛋白酶，它在賴氨酸之后切割其切割位點(diǎn)Asp-Asp-Asp-Asp-Lys。有時(shí)它會(huì)切割其他堿性殘基，這取決于蛋白質(zhì)底物的構(gòu)象。
生物活性：在25°C，反應(yīng)緩沖液為50 mM Tris-HCl (pH 8.0)時(shí)，定義消化包含消化位點(diǎn)的50微克融合蛋白所需酶的量為1單位的酶活性，即1U。
表達(dá)系統(tǒng)：酵母
物種：牛
蛋白質(zhì)長度：人腸激酶從牛身上克隆并表達(dá)在酵母中。
目標(biāo)：胰蛋白酶原激活酶
濃度：> 30 KU / mg, 1mg的重組牛腸激酶可以切割至少1.5g融合蛋白。
應(yīng)用程序：融合蛋白切割，蛋白質(zhì)純化，蛋白質(zhì)消化
運(yùn)輸：通常，蛋白質(zhì)以凍干粉/冷凍液形式提供。除非客戶另有要求，否則用干冰/藍(lán)冰發(fā)貨。
穩(wěn)定性和儲(chǔ)存：使用手動(dòng)除霜冷凍庫，并避免反復(fù)的冷凍解凍循環(huán)。在2至8°C儲(chǔ)存一周。自收到之日起在-20至-80°C儲(chǔ)存十二個(gè)月。
目標(biāo)客戶群體
科研機(jī)構(gòu)：高校、研究所的分子生物學(xué)、免疫學(xué)實(shí)驗(yàn)室。
制藥與生物技術(shù)公司：抗體藥物開發(fā)、靶點(diǎn)驗(yàn)證及臨床前研究。
臨床診斷實(shí)驗(yàn)室：疾病標(biāo)志物檢測(cè)、個(gè)性化醫(yī)療研究。
教育機(jī)構(gòu)：生命科學(xué)教學(xué)與實(shí)驗(yàn)技術(shù)支持。
常見問題與解答
Q1：AntibodySystem的抗體是否適用于復(fù)雜樣本（如血清、組織裂解液）？
A：是的。產(chǎn)品經(jīng)過低內(nèi)毒素處理，且特異性高，可減少非特異性結(jié)合，適用于血清、細(xì)胞裂解液等復(fù)雜樣本。
Q2：如何選擇流式抗體與功能驗(yàn)證抗體？
A：根據(jù)實(shí)驗(yàn)需求選擇：
流式抗體：優(yōu)先選擇SAA系列（低背景、高穩(wěn)定性）。
功能驗(yàn)證：推薦Invivo系列（如小鼠PSCA抗體），支持體內(nèi)長期實(shí)驗(yàn)。
Q3：供貨周期與定制服務(wù)如何？
A：常規(guī)產(chǎn)品現(xiàn)貨供應(yīng)，定制抗體開發(fā)周期約8-12周，支持小批量訂單。
Q4：是否提供技術(shù)支持與文獻(xiàn)引用案例？
A：提供免費(fèi)技術(shù)咨詢及實(shí)驗(yàn)方案優(yōu)化建議。及合作平臺(tái)可查詢產(chǎn)品引用文獻(xiàn)。
Q5：價(jià)格與代理渠道是否透明？
A：價(jià)格根據(jù)產(chǎn)品類型與采購量靈活調(diào)整，中國區(qū)由上海起發(fā)授權(quán)代理分銷，確保正品與售后保障。
熱銷產(chǎn)品
貨號(hào) | 品名 | 規(guī)格 | 品牌 |
RVV14601-100ug | Anti-Parainfluenza virus 5/PIV5 Protein P Antibody (SAA0288) | 100ug | antibodysystem |
RVV02817-Biotin-100ug | Anti-RSV F/Fusion glycoprotein F0 Antibody (4D7)-Biotin | 100ug | antibodysystem |
RVV02817-Biotin-1mg | Anti-RSV F/Fusion glycoprotein F0 Antibody (4D7)-Biotin | 1mg | antibodysystem |
RVV14601-1mg | Anti-Parainfluenza virus 5/PIV5 Protein P Antibody (SAA0288) | 1mg | antibodysystem |
RGK24801-100ug | Anti-RNA Antibody (D444) | 100ug | antibodysystem |
FHF14610-50ug | Anti-Human FCGRT/FCRN Antibody (SAA0135) | 50ug | antibodysystem |
FHC02010-50ug | Anti-Human CD71/TFRC Antibody (JR-141) | 50ug | antibodysystem |
DHC19102 | Research Grade Anti-Human CD220/INSR (AGT-182) | 100ug | antibodysystem |
DHE85605-100ug | Research Grade Anti-Human CD198/CCR8 (BMS-986340) | 100 ug | antibodysystem |
DHE85605-1mg | Research Grade Anti-Human CD198/CCR8 (BMS-986340) | 1 mg | antibodysystem |
YHJ37101-100ug | Recombinant Human FUBP1, N-His | 100ug | antibodysystem |
DHE85605-30mg | Research Grade Anti-Human CD198/CCR8 (BMS-986340) | 30 mg | antibodysystem |
FHE51810-50ug | Anti-Human GCGR Antibody (SAA0132) | 50ug | antibodysystem |
RHK08201-100ug | Anti-Human Abeta42/Beta-APP42 Antibody (21F12) | 100ug | antibodysystem |
RHK08201-1mg | Anti-Human Abeta42/Beta-APP42 Antibody (21F12) | 1mg | antibodysystem |
DHD29901-100ug | Research Grade Anti-Human ITGB6 (SGN-B6A) | 100ug | antibodysystem |
EVV13501-100ug | Recombinant Monkeypox virus/MPXV B6R/SL-159 Protein, C-His | 100ug | antibodysystem |
YVV13301-100ug | Recombinant Monkeypox virus/MPXV M1R Protein, N-His | 100ug | antibodysystem |
YVV13101-100ug | Recombinant Monkeypox virus/MPXV A35R Protein, N-His | 100ug | antibodysystem |
DHJ70901-100ug | Research Grade MOR106 | 100ug | antibodysystem |
PHE26002-50ug | Anti-Romiplostim Polyclonal Antibody | 50ug | antibodysystem |
FHA05310-50ug | Anti-Human CD284/TLR4 Antibody (SAA0095) | 50ug | antibodysystem |
DHC04202-1mg | Research Grade Abelacimab | mg | antibodysystem |
RVV15101-100ug | Anti-EBV/HHV-4 gH/BXLF2 Antibody (CL40) | 100ug | antibodysystem |
YMA70801-1mg | Recombinant Mouse CD258/TNFSF14/LIGHT Protein, N-His | 1mg | antibodysystem |
AID00601-100ug | Recombinant Human PLA2R1 Protein | 100ug | antibodysystem |
VVV00311 | InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing Antibody (Iv0221) | 100ug | antibodysystem |
DHB95401-1mg | Research Grade Emapalumab | 1mg | antibodysystem |
EHK60701-1mg | Recombinant Human CRBN & DDB1 Protein, N-Strep & C-His | 1mg | antibodysystem |
DHD50503-1mg | Research Grade Anti-Human CDH3/P-cadherin (PCA062) | 1mg | antibodysystem |
VVV00312-100ug | InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing Antibody (Iv0222) | 100ug | antibodysystem |
YHD10401-100ug | Recombinant Human FOLR1, N-His | 100ug | antibodysystem |
YHD03501-100ug | Recombinant Human FOLR2, N-His | 100ug | antibodysystem |
DHC12502-100ug | Research Grade Donanemab | 100ug | antibodysystem |
RVV15201-1mg | Anti-EBV/HHV-4 BLLF1/MA Antibody (72A1) | 1mg | antibodysystem |
FHD18110-100ug | Anti-Human TSHR/LGR3 Antibody (M22) (FHD18110) | 100ug | antibodysystem |
RVV02817-5mg | Anti-RSV F/Fusion glycoprotein F0 Antibody (4D7) | 5mg | antibodysystem |
FHD18110-1mg | Anti-Human TSHR/LGR3 Antibody (M22) (FHD18110) | 1mg | antibodysystem |
YHK13001-100ug | Recombinant Human TRPV6/ECaC2 Protein, N-His | 100ug | antibodysystem |
YMB94401-1mg | Recombinant Mouse TNFa/TNF-alpha, N-His | 1mg | antibodysystem |
FMC02020-50ug | Anti-Mouse CD71/TFRC Antibody (OX-26) | 50ug | antibodysystem |
DHC43302-1g | Research Grade Datopotamab | 1g | antibodysystem |
PVV09001-100ug | Anti-HPV18 E6/Protein E6 Polyclonal Antibody | 100ug | antibodysystem |
RVV08903-100ug | Anti-HPV16 E7/Protein E7 Antibody (Nb4) | 100ug | antibodysystem |
EVV15102-100ug | Recombinant EBV/HHV4 gH & gL Complex, C-Strep & C-His | 100ug | antibodysystem |
EVV15201-100ug | Recombinant EBV/HHV4 BLLF1/MA/GP350 Protein, C-His | 100ug | antibodysystem |
EVV15104-100ug | Recombinant EBV/HHV-4 gH/BXLF2 Protein, C-Strep | 100ug | antibodysystem |
RVV09801-100ug | Anti-VSV G/Glycoprotein G Antibody (2F7) | 100ug | antibodysystem |
RVV09902-100ug | Anti-VSV NP/Nucleoprotein Antibody (1307) | 100ug | antibodysystem |
RVV09804-100ug | Anti-VSV G/Glycoprotein G Antibody (1A10) | 100ug | antibodysystem |
RVV09904-100ug | Anti-VSV NP/Nucleoprotein Antibody (1001) | 100ug | antibodysystem |
DHJ24004-1mg | Research Grade Bococizumab | 1mg | antibodysystem |
EVV02804-100ug | Recombinant HRSV F/Fusion glycoprotein F0 Protein, C-His | 100ug | antibodysystem |
EVV02801-100ug | Recombinant HRSV-A2 Pre-F/Fusion glycoprotein F0, C-His & C-Strep | 100ug | antibodysystem |
FHE32810-50ug | Anti-Human ADCYAP1R1 Antibody (SAA0130) | 50ug | antibodysystem |
FHG01310-100ug | Anti-Human FOLH1/PSMA Antibody (J591) | 100ug | antibodysystem |
DHK23201-100ug | Research Grade Anti-Human TNFRSF25 Antibody (PTX-35) | 100ug | antibodysystem |
DHD34002 | Research Grade Anti-Human CD120a/TNFRSF1A/TNFR1 (ATROSAB) | 100 ug | antibodysystem |
MGK07901-100ug | Anti-6 X His Tag (HHHHHH) Monoclonal Antibody (1A056) | 100ug | antibodysystem |
EHJ05001-100ug | Recombinant Human IL31 Protein, C-His | 100ug | antibodysystem |
DHD58802-1mg | Research Grade Amlitelimab | 1 mg | antibodysystem |
PAD62601-100ug | Anti-Dupilumab Polyclonal Antibody | 100ug | antibodysystem |
DHE43207-5mg | Research Grade Rocatinlimab | 5mg | antibodysystem |
DHE43207-4mg | Research Grade Rocatinlimab | 4mg | antibodysystem |
FHJ92520-100ug | Human IgA2, lambda Isotype Control antibody (13R4) | 100ug | antibodysystem |
VME85601 | InVivoMAb Anti-Mouse CD198/CCR8 Antibody (Iv0255) (VME85601) | 1mg | antibodysystem |
DHE84602 | Anti-Human GPC3 8 CD3E Antibody (ERY974) | 100UG | antibodysystem |
VVV03701-100ug | InVivoMAb Anti-HBV-A S-HBsAg/SHB Antibody (Iv0151) | 100ug | antibodysystem |
PTB96431-100ul | Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP | 100ul | antibodysystem |
DHD72801-100ug | Research Grade Bimagrumab | 100ug | antibodysystem |
DHB54003-100ug | Research Grade Anti-Human TNFSF15/TL1A (PRA023) | 100ug | antibodysystem |
DHC25203-1mg | Research Grade Axatilimab | 1mg | antibodysystem |
RGK30901-50ug | Anti-EPEA Tag (C-tag) Antibody (SAA0356) | 50ug | antibodysystem |
RGK30901-100ug | Anti-EPEA Tag (C-tag) Antibody (SAA0356) | 100ug | antibodysystem |
RVV25101-100ug | Anti-EBV/HHV-4 GP42/Glycoprotein 42 Antibody (SAA2098) | 100ug | antibodysystem |
RVV13902-100ug | Anti-Vaccinia virus(VACV) L1R/Protein L1 Antibody (M12B9) | 100ug | antibodysystem |
RVV13901-100ug | Anti-Vaccinia virus(VACV) L1R/Protein L1 Antibody (7D11) | 100ug | antibodysystem |
RVV03302-100ug | Anti-Influenza A virus NP/Nucleoprotein Antibody (SAA0411) | 100ug | antibodysystem |
YXX05101-100ug | IdeZ Protease (IgG specific) | 100ug | antibodysystem |
DHJ31005 | Research Grade Ubam atamab (DHJ31005) | 1MG | antibodysystem |
DHG84901-100ug | Research Grade Anti-Human IL11RA Antibody (X209) (DHG84901) | 100 ug | antibodysystem |
PMJ12101-100ug | Anti-Mouse ADAMTS13 Polyclonal Antibody | 100ug | antibodysystem |
FHG31410-50ug | Anti-Human CDH17 Antibody (SAA0347) | 50ug | antibodysystem |
YHC44101-100ug | Recombinant Human IFIT1 Protein, N-His | 100ug | antibodysystem |
YHB74601-100ug | Recombinant Human DDX58, N-His | 100ug | antibodysystem |
DHE43207-100ug | Research Grade Rocatinlimab | 100 ug | antibodysystem |
FHG32211-50T | Anti-Human FAP Antibody (SAA0473), FITC | 50T | antibodysystem |
FHE84611-50T | Anti-Human GPC3 Antibody (SAA0134), FITC | 50T | antibodysystem |
DVV02811-100ug | Research Grade Anti-RSV F/Fusion glycoprotein F0 (ADI-14359) (DVV02811) | 100ug | antibodysystem |
DVV02802-100ug | Research Grade Nirsevimab (DVV02802) | 100ug | antibodysystem |
RVV02816-100ug | Anti-HRSV-A F/Fusion glycoprotein F0 Antibody (101F) | 100ug | antibodysystem |
DVV02813-100ug | Research Grade Anti-RSV F/Fusion glycoprotein F0 (hRSV90) (DVV02813) | 100ug | antibodysystem |
FHJ92840-100ug | Human IgG1 Isotype Control Antibody (HyHEL-10) | 100ug | antibodysystem |
FMJ92810-100ug | Mouse IgG1 Isotype Control Antibody (HyHEL-10) | 100ug | antibodysystem |
RVV15301-100ug | Anti-EBV/HHV-4 EBNA1/BKRF1 Antibody (3D4) | 100ug | antibodysystem |
DHJ05001-100ug | Research Grade Anti-Human IL31 (BMS-981164) | 100 ug | antibodysystem |
FHC88110-100ug | Anti-Human CD331/FGFR1 Antibody (A08) | 100ug | antibodysystem |
FHK06421 | Anti-Human DLL3 Antibody (SAA1488), FITC (FHK06421) | 50T | antibodysystem |
DHD97903-100ug | Research Grade Anti-Human CD32b/FCGR2B (BI-1206) (DHD97903) | 100ug | antibodysystem |
DVV03807-100ug | Research Grade Anti-Influenza A virus HA/Hemagglutinin Broad-Neutralizing Antibody (CR9114) (DVV03807) | 100ug | antibodysystem |
